Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New antimitotic drugs from Pharmacia & Upjohn

March 15, 1996

More approvals for Taxotere

March 15, 1996

Paclitaxel derivatives from Bristol-Myers Squibb

March 15, 1996

FDA gives green light to Immunex's etoposide

March 15, 1996

European clinical trial results with irinotecan reported

March 15, 1996

PK1 to enter phase II

March 15, 1996

MEN-10746 selected for development

March 15, 1996

MEN-10755 named as candidate for clinical study

March 15, 1996

Inex reports on liposomal vincristine development

March 15, 1996

Kirin anticancer drug in clinical trials

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...